Table 3.
Adjuvant therapy. Carcinosarcomas were distinguished in the table to make the comparison between the tumours easier.
| Variables | Total (n = 161) | LMS (n = 51) | ESS (n = 31) | CS (n = 73) | Others (n = 6) | p |
|---|---|---|---|---|---|---|
| Mean ± S.T. n (%) | Mean ± S.T. n (%) | Mean ± S.T. n (%) | Mean ± S.T. n (%) | Mean ± S.T. n (%) | ||
| Adjuvant treatment | 86 (53.4%) | 19 (37.3%) | 12 (38.7%) | 55 (75.3%) | 0 (0%) | <0.01 |
| Adjuvant chemotherapy | 36 (22.4%) | 9 (17.6%) | 4 (12.9%) | 23 (31.5%) | 0 (0%) | 0.113 |
| Adjuvant radiotherapy | 65 (40.4%) | 12 (23.5%) | 9 (29%) | 44 (60.3%) | 0 (0%) | <0.01 |
| Adjuvant chemotherapy + adjuvant radiotherapy | 15 (9.31%) | 2 (3.9%) | 1 (3.2%) | 12 (16.4%) | 0 (0%) | |
| Type of radiotherapy | <0.01 | |||||
| External | 28 (17.3%) | 11 (21.5%) | 5 (16.1%) | 13 (17.8%) | 1 (16.6%) | |
| External + Brachytherapy | 36 (22.3%) | 1 (1.96%) | 5 (16.1%) | 31 (42.4%) | 0 (0%) | |
| No adyuvant radiotherapy | 97 (60.2%) | 39 (76.4%) | 21 (67.7%) | 29 (39.7%) | 5 (83.3%) |